长江生命科技(00775)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00775 长江生命科技

已收盘 11-19 16:08:17

0.445

-0.005

-1.11%

最高0.455	最低0.445	成交量66.20万
今开0.450	昨收0.450	日振幅2.22%
总市值42.77亿	流通市值42.77亿	总股本96.11亿
成交额29.71万	换手率0.01%	流通股本96.11亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00775","market":"HK","secType":"STK","nameCN":"长江生命科技","latestPrice":0.445,"timestamp":1732003697010,"preClose":0.45,"halted":0,"volume":662000,"delay":0,"floatShares":9611072400,"shares":9611072400,"eps":0.001794,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.005,"latestTime":"11-19 16:08:17","open":0.45,"high":0.455,"low":0.445,"amount":297050,"amplitude":0.022222,"askPrice":0.45,"askSize":190000,"bidPrice":0.445,"bidSize":260000,"shortable":0,"etf":0,"ttmEps":-0.001941,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732066200000},"adr":0,"adjPreClose":0.45,"dividendRate":0.017978,"openAndCloseTimeList":[[1731979800000,1731988800000],[1731992400000,1732003200000]],"volumeRatio":0.472319,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00775","defaultTab":"news","newsList":[{"id":"2479711400","title":"长江生命科技(00775)上涨5.68%，报0.465元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2479711400","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479711400?lang=zh_cn&edition=full","pubTime":"2024-10-31 10:30","pubTimestamp":1730341836,"startTime":"0","endTime":"0","summary":"10月31日，长江生命科技(00775)盘中上涨5.68%，截至10:30，报0.465元/股，成交105.63万元。长江生命科技集团有限公司的主营业务是产品的研发、制造、商品化、推广、销售及投资，主要涵盖保健、医药与诊断以及农业相关业务。该公司是长江和记实业集团的一部分，并在香港联合交易所有限公司上市。截至2024年中报，长江生命科技营业总收入24.06亿元、净利润91.36万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/31103044770861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1569","BK1161","00775"],"gpt_icon":0},{"id":"2479671340","title":"长江生命科技盘中异动 股价大涨6.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479671340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479671340?lang=zh_cn&edition=full","pubTime":"2024-10-31 09:36","pubTimestamp":1730338573,"startTime":"0","endTime":"0","summary":"2024年10月31日早盘09时36分，长江生命科技股票出现波动，股价快速拉升6.82%。长江生命科技股票所在的药品行业中，整体涨幅为0.05%。其相关个股中，长江生命科技、兆科眼科-B、中国同辐涨幅较大，振幅较大的相关个股有长江生命科技、艾美疫苗、丽珠医药，振幅分别为7.95%、5.47%、3.26%。长江生命科技公司简介：长江生命科技集团有限公司是一家主要从事健康产品研发及销售业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031093613971a35b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031093613971a35b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1569","BK1161","00775"],"gpt_icon":0},{"id":"2475546630","title":"长江生命科技(00775)下跌5.88%，报0.48元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2475546630","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475546630?lang=zh_cn&edition=full","pubTime":"2024-10-15 15:45","pubTimestamp":1728978343,"startTime":"0","endTime":"0","summary":"10月15日，长江生命科技(00775)盘中下跌5.88%，截至15:45，报0.48元/股，成交242.89万元。长江生命科技集团有限公司的主营业务是产品的研发、制造、商品化、推广、销售及投资，主要涵盖保健、医药与诊断以及农业相关业务。该公司是长江和记实业集团的一部分，并在香港联合交易所有限公司上市。截至2024年中报，长江生命科技营业总收入24.06亿元、净利润91.36万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/15154544009050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1569","BK1161","00775"],"gpt_icon":0},{"id":"2475754522","title":"长江生命科技盘中异动 急速下挫5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475754522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475754522?lang=zh_cn&edition=full","pubTime":"2024-10-15 15:45","pubTimestamp":1728978340,"startTime":"0","endTime":"0","summary":"2024年10月15日临近收盘15时45分，长江生命科技股票出现异动，股价大幅下跌5.88%。截至发稿，该股报0.480港元/股，成交量491.6万股，换手率0.05%，振幅5.88%。长江生命科技股票所在的药品行业中，整体跌幅为0.59%。长江生命科技公司简介：长江生命科技集团有限公司是一家主要从事健康产品研发及销售业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101515454098e3c7ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101515454098e3c7ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1569","00775","BK1161"],"gpt_icon":0},{"id":"2474733779","title":"【特约大V】邓声兴：中央周六召开会议，或有利港股稍微反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=2474733779","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474733779?lang=zh_cn&edition=full","pubTime":"2024-10-10 09:01","pubTimestamp":1728522080,"startTime":"0","endTime":"0","summary":"国指挫1.6%，报7365；科指则挫1.17%，收4640。波音公司的信贷评级可能被降至垃圾级别，加上与工会的谈判破裂，股价下滑3.4%，为跌幅最大道指成份股。中央周六召开会议，或有利港股稍微反弹。这次WEX与Virios合并是长江生命科技策略性发展里程碑。VIRI拥有痛症领域的研发及商业化经验，透过今次交易，可带来一个新的融资渠道，有利WEX于美国资本市场进行融资及扩大研发团队。","market":"nz","thumbnail":"https://static.szfiu.com/news/20200915/NGFkNTk3NmM5ZjkwMzU0MDAwMzc1OTcxMzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NGFkNTk3NmM5ZjkwMzU0MDAwMzc1OTcxMzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1945637","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09888","NKE","BK1161","TSLA","YANG","GOOGL","03690","BK1569","HSTECH","META","AAPL","00775","BA"],"gpt_icon":1},{"id":"2474218914","title":"长江生命科技10月09日主力资金流出109万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2474218914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474218914?lang=zh_cn&edition=full","pubTime":"2024-10-09 16:16","pubTimestamp":1728461771,"startTime":"0","endTime":"0","summary":"10月09日, 长江生命科技股价跌9.26%，报收0.49元，成交金额1086万元，换手率0.22%，振幅18.52%，量比0.87。长江生命科技今日主力资金净流出109万元，连续3日净流出，上一交易日主力净流出553万元，今日环比减少80.29%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为44.44%，平均跌幅为2.11%。该股近5个交易日上涨15.12%，主力资金累计净流出519万元；近20日主力资金累计净流出423万元，其中净流出天数为7日。该股主力净额占比0.02%，港股市场排名2310/2640。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410091617229f343d6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410091617229f343d6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","00775","BK1569"],"gpt_icon":0},{"id":"2474025382","title":"长江生命科技(00775)上涨7.41%，报0.58元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474025382","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474025382?lang=zh_cn&edition=full","pubTime":"2024-10-09 09:44","pubTimestamp":1728438278,"startTime":"0","endTime":"0","summary":"10月9日，长江生命科技(00775)盘中上涨7.41%，截至09:44，报0.58元/股，成交107.09万元。长江生命科技集团有限公司的主营业务是产品的研发、制造、商品化、推广、销售及投资，主要涵盖保健、医药与诊断以及农业相关业务。该公司是长江和记实业集团的一部分，并在香港联合交易所有限公司上市。截至2024年中报，长江生命科技营业总收入24.06亿元、净利润91.36万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/09094443814119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","00775","BK1569"],"gpt_icon":0},{"id":"2474258640","title":"长江生命科技盘中异动 早盘大幅上涨5.56%报0.570港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474258640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474258640?lang=zh_cn&edition=full","pubTime":"2024-10-09 09:42","pubTimestamp":1728438123,"startTime":"0","endTime":"0","summary":"2024年10月09日早盘09时42分，长江生命科技股票出现异动，股价大幅拉升5.56%。截至发稿，该股报0.570港元/股，成交量175.8万股，换手率0.02%，振幅7.41%。长江生命科技股票所在的药品行业中，整体跌幅为0.09%。其相关个股中，长江生命科技、培力农本方、三爱健康集团涨幅较大，振幅较大的相关个股有培力农本方、艾美疫苗、康龙化成，振幅分别为10.53%、9.05%、7.51%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100909420398e3b48b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100909420398e3b48b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1569","00775","BK1161"],"gpt_icon":0},{"id":"2473411766","title":"长江生科(00775.HK)期望可为新合并公司Dogwood(DWTX.US)引入投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2473411766","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473411766?lang=zh_cn&edition=full","pubTime":"2024-10-08 15:12","pubTimestamp":1728371520,"startTime":"0","endTime":"0","summary":"长江生命科技宣布旗下WEX Pharmaceuticals与纳斯达克上市生物科技公司Virios Therapeutics进行业务合并，交易完成后长江生科于VIRI持股约15.9%，并获授予可转换的优先股，当优先股转换为普通股后持股量将增至约90.7%。新合并公司将更名为Dogwood Therapeutics，并维持美国上市地位。余英才补充，由于该项目已准备好推展三期试验，因此公司会优先对其投放资金。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20241008151508513_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20241008151508513_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1386736/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1569","BK1161","00775"],"gpt_icon":0},{"id":"2473041305","title":"长江生命科技与买方达成1亿美元股权出售及1950万美元贷款协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2473041305","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473041305?lang=zh_cn&edition=full","pubTime":"2024-10-08 15:04","pubTimestamp":1728371082,"startTime":"0","endTime":"0","summary":"财中社10月8日电长江生命科技（00775）发布公告，宣布与买方达成一项涉及目标公司100%已发行在外普通股的售股协议，总代价为1亿美元（约7.8亿港元），该代价将通过买方向卖方发行代价股份的方式支付。此外，长江生命科技还将向买方提供最多1950万美元（约1.52亿港元）的贷款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202410083198481646.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1569","BK1161","00775"],"gpt_icon":0},{"id":"2473466479","title":"长江生命科技现涨逾6% 涉资1亿美元出售附属WEX换VIRI股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2473466479","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473466479?lang=zh_cn&edition=full","pubTime":"2024-10-08 10:29","pubTimestamp":1728354569,"startTime":"0","endTime":"0","summary":"长江生命科技股价上涨5.77%，现报0.55港元，成交额1631.76万港元。　　长江生命科技发布公告，于2024年10月7日，公司间接全资附属Sealbond Limited拟向Virios Therapeutics， Inc．出售一间加拿大公司 Pharmagesic  Inc.100%已发行在外普通股，总代价为1亿美元，将透过买方向卖方发行代价股份的方式支付。　　此外，贷款人与买方订立贷款协议，据此，贷款人同意向买方提供本金总额最多达 1950万美元的贷款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-10-08/doc-incruzvc1007490.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-10-08/doc-incruzvc1007490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1569","BK1161","00775"],"gpt_icon":0},{"id":"2473975465","title":"港股异动 | 长江生命科技(00775)涨超7% 涉资1亿美元出售附属WEX换VIRI股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2473975465","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473975465?lang=zh_cn&edition=full","pubTime":"2024-10-08 09:50","pubTimestamp":1728352200,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，长江生命科技涨超7%，截至发稿，涨7.69%，报0.56港元，成交额1206.94万港元。据悉，目标公司为一间加拿大公司。目标公司拥有WEX的100%已发行在外普通股，WEX主要从事创新止痛药品的研发、生产及商品化。WEX的旗舰候选产品Halneuron为一种目前处于研发阶段的高度选择性钠通道阻滞剂，用于治疗因化疗引致的中度至严重神经痛症、癌症引致的痛楚及其他疼痛适应症。于交易完成前，目标公司由卖方全资拥有，并为该公司间接全资附属公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1190773.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK4106","BK4227","00775","LU1861220207.SGD","VIRI","BK1569","LU2360107671.USD","WEX","LU1861217088.USD","BK1161"],"gpt_icon":0},{"id":"2473468011","title":"长江生命科技拟售子公司全股并贷1950万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473468011","media":"地产k线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473468011?lang=zh_cn&edition=full","pubTime":"2024-10-08 09:37","pubTimestamp":1728351442,"startTime":"0","endTime":"0","summary":"长江生命科技今日宣布，已与买方签署售股协议，以约7.8亿港元出售其全资目标公司100%股权。此外，长江生命科技的间接全资子公司还将提供高达152.1百万港元的贷款给买方，以支持交易，贷款分两期发放。此次交易的核心目的旨在推动目标公司WEX与买方在生物科技领域的深度融合，利用买方的专业知识和资源，加速WEX及其核心产品Halneuron的研发与市场推广进程。预计交易完成后，WEX的产品研发将更加高效，市场准入速度显著提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080955069596d355&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080955069596d355&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","00775","BK1569"],"gpt_icon":0},{"id":"2473576624","title":"长江生命科技盘中异动 早盘大幅上涨15.38%报0.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473576624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473576624?lang=zh_cn&edition=full","pubTime":"2024-10-08 09:30","pubTimestamp":1728351004,"startTime":"0","endTime":"0","summary":"2024年10月08日早盘09时30分，长江生命科技股票出现异动，股价快速拉升15.38%。截至发稿，该股报0.600港元/股，成交量319.4万股，换手率0.03%，振幅3.85%。资金方面，该股资金流入4.88万港元，流出44.046万港元。长江生命科技股票所在的药品行业中，整体涨幅为0.66%。其相关个股中，华控康泰、长江生命科技、艾美疫苗涨幅较大，振幅较大的相关个股有华控康泰、兆科眼科-B、长江生命科技，振幅分别为16.22%、5.49%、3.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008093004ab6837bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008093004ab6837bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","00775","BK1569"],"gpt_icon":1},{"id":"2473312459","title":"长江生命科技(00775.HK)旗下WEX与美股上市生物科企合并","url":"https://stock-news.laohu8.com/highlight/detail?id=2473312459","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473312459?lang=zh_cn&edition=full","pubTime":"2024-10-08 08:00","pubTimestamp":1728345600,"startTime":"0","endTime":"0","summary":"长江生命科技公布，旗下全资附属公司Sealbond Limited 与纳斯达克上市生物科技公司Virios Therapeutics, Inc. 达成协议。Virios Therapeutics, Inc.将发行价值1亿美元之新股以收购WEX的母公司。紧随交易完成后，长江生命科技将透过Sealbond持有VIRI约15.9%的已发行普通股。长江生命科技亦同意，透过全资附属公司以贷款形式提供达1,950万美元之策略性融资，以加快WEX发展临床及研发活动。长江生命科技副主席及执行董事余英才表示，WEX与VIRI合并乃长江生命科技的一个策略性发展里程碑。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221024111456370_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221024111456370_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1386554/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1569","BK1161","00775"],"gpt_icon":0},{"id":"2473475103","title":"长江生命科技(00775.HK)出售附属WEX换VIRI股权  涉资1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473475103","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473475103?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:34","pubTimestamp":1728308040,"startTime":"0","endTime":"0","summary":"长江生命科技(00775.HK) 公布，向纳斯达克上市公司Virios Therapeutics, Inc.(VIRI)出售创新止痛药附属-WEX 100%股本，总代价1亿美元，VIRI将透过发行21.13万股普通股；及2,108万优先股支付。完成发行普通股后，公司将持有VIRI股本约15.9%；优先股获行使后，公司于VIRI持股将增至90.7%。同时，公司将向VIRI提供最多1,950万美元贷款，主要用于WEX进行有关旗舰产品Halneuron之营运及进行临床及研发资金。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221024111457745_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221024111457745_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1386484/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1569","00775","BK1161"],"gpt_icon":0},{"id":"2473174873","title":"长江生命科技(00775)拟1亿美元出售一间加拿大公司 Pharmagesic (Holdings) Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2473174873","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473174873?lang=zh_cn&edition=full","pubTime":"2024-10-07 19:55","pubTimestamp":1728302155,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长江生命科技 公布，于2024年10月7日，公司间接全资附属Sealbond Limited拟向Virios Therapeutics, Inc.出售一间加拿大公司 Pharmagesic  Inc.100%已发行在外普通股，总代价为1亿美元，将透过买方向卖方发行代价股份的方式支付。据悉，目标公司为一间加拿大公司。公告称，该等交易将导致由目标公司全资拥有的 WEX 与买方进行业务合并。根据贷款协议向买方提供的贷款亦将支持研发 Halneuron 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1190656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1569","00775"],"gpt_icon":0},{"id":"2473311189","title":"长江生命科技盘中异动 股价大涨6.38%报0.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473311189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473311189?lang=zh_cn&edition=full","pubTime":"2024-10-07 09:32","pubTimestamp":1728264769,"startTime":"0","endTime":"0","summary":"2024年10月07日早盘09时32分，长江生命科技股票出现异动，股价大幅上涨6.38%。截至发稿，该股报0.500港元/股，成交量66万股，换手率0.01%，振幅5.32%。资金方面，该股资金流入18.494万港元，流出5.105万港元。长江生命科技股票所在的药品行业中，整体涨幅为0.90%。其相关个股中，四环医药、艾美疫苗、三爱健康集团涨幅较大，振幅较大的相关个股有四环医药、艾美疫苗、三爱健康集团，振幅分别为23.61%、18.89%、17.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007093249ab6804d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007093249ab6804d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1569","00775"],"gpt_icon":0},{"id":"2472986371","title":"长江生命科技(00775)股价显著上升12.791%，现价港币$0.485","url":"https://stock-news.laohu8.com/highlight/detail?id=2472986371","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472986371?lang=zh_cn&edition=full","pubTime":"2024-10-04 14:00","pubTimestamp":1728021600,"startTime":"0","endTime":"0","summary":"[上升股]长江生命科技(00775) 股价在下午02:00比前收市价显著上升12.791%，现股价为港币$0.485。至目前为止，今日最高价为$0.485，而最低价为$0.43。总成交量为1.053千万股，总成交金额为港币$478.729万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2410045580/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","00775","BK1569"],"gpt_icon":0},{"id":"2472983017","title":"长江生命科技盘中异动 下午盘大幅上涨5.81%报0.455港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472983017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472983017?lang=zh_cn&edition=full","pubTime":"2024-10-04 13:34","pubTimestamp":1728020072,"startTime":"0","endTime":"0","summary":"2024年10月04日下午盘13时34分，长江生命科技股票出现波动，股价急速拉升5.81%。截至发稿，该股报0.455港元/股，成交量529.095万股，换手率0.06%，振幅5.81%。资金方面，该股资金流入139.975万港元，流出89.544万港元。长江生命科技股票所在的药品行业中，整体涨幅为1.10%。长江生命科技公司简介：长江生命科技集团有限公司是一家主要从事健康产品研发及销售业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410041334329719e551&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410041334329719e551&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1569","00775"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ck-lifesciences.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0722},{"period":"3month","weight":0.3235},{"period":"6month","weight":0.0843},{"period":"1year","weight":-0.3182},{"period":"ytd","weight":-0.2742}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.059},{"period":"3month","weight":0.118},{"period":"6month","weight":0.0198},{"period":"1year","weight":0.1216},{"period":"ytd","weight":0.1484}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"长江生命科技集团有限公司是一家主要从事健康产品研发及销售业务的香港投资控股公司。该公司通过三个分部运营。人类健康分部从事保健产品及医药产品的研发、生产、推广及销售业务。该公司旗下保健产品品牌包括Lipa，Vitaquest以及Sante Naturelle等。其研发药物产品主要包括癌症相关药物及止痛药物等。农业相关业务分部经营葡萄园以及研发、生产、推广及销售农业及相关产品。其农业产品包括肥料产品及植物保护产品等。投资分部投资于金融及投资产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.004007},{"month":2,"riseRate":0.5,"avgChangeRate":0.034166},{"month":3,"riseRate":0.136364,"avgChangeRate":-0.08184},{"month":4,"riseRate":0.590909,"avgChangeRate":0.037147},{"month":5,"riseRate":0.454545,"avgChangeRate":0.020644},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.011826},{"month":7,"riseRate":0.5,"avgChangeRate":0.007731},{"month":8,"riseRate":0.347826,"avgChangeRate":-0.015966},{"month":9,"riseRate":0.217391,"avgChangeRate":-0.025203},{"month":10,"riseRate":0.347826,"avgChangeRate":-0.017193},{"month":11,"riseRate":0.521739,"avgChangeRate":0.067939},{"month":12,"riseRate":0.363636,"avgChangeRate":0.001392}],"exchange":"SEHK","name":"长江生命科技","nameEN":"CKLIFE SCIENCES"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"长江生命科技(00775)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供长江生命科技(00775)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"长江生命科技,00775,长江生命科技股票,长江生命科技股票老虎,长江生命科技股票老虎国际,长江生命科技行情,长江生命科技股票行情,长江生命科技股价,长江生命科技股市,长江生命科技股票价格,长江生命科技股票交易,长江生命科技股票购买,长江生命科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"长江生命科技(00775)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供长江生命科技(00775)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}